FMS-like tyrosine kinase 3 (FLT3) gene mutation is one of the common mutations seen in AML in up to 30% of newly diagnosed cases, recognized as a proliferative signal associated with poor prognosis. The gene discussed is FLT3; the disease is acute myeloid leukemia.